Article

Luabeya KK, Mpontshane N, Mackay M, Ward H, Elson I, Chhagan M et al.. Zinc or multiple micronutrient supplementation to reduce diarrhea and respiratory disease in South African children: a randomized controlled trial. PLoS ONE 2, e541

Africa Centre for Health and Population Studies, University of KwaZulu Natal, Somkhele, South Africa.
PLoS ONE (Impact Factor: 3.23). 02/2007; 2(6):e541. DOI: 10.1371/journal.pone.0000541
Source: PubMed

ABSTRACT Prophylactic zinc supplementation has been shown to reduce diarrhea and respiratory illness in children in many developing countries, but its efficacy in children in Africa is uncertain.
To determine if zinc, or zinc plus multiple micronutrients, reduces diarrhea and respiratory disease prevalence.
Randomized, double-blind, controlled trial.
Rural community in South Africa.
THREE COHORTS: 32 HIV-infected children; 154 HIV-uninfected children born to HIV-infected mothers; and 187 HIV-uninfected children born to HIV-uninfected mothers.
Children received either 1250 IU of vitamin A; vitamin A and 10 mg of zinc; or vitamin A, zinc, vitamins B1, B2, B6, B12, C, D, E, and K and copper, iodine, iron, and niacin starting at 6 months and continuing to 24 months of age. Homes were visited weekly.
Primary outcome was percentage of days of diarrhea per child by study arm within each of the three cohorts. Secondary outcomes were prevalence of upper respiratory symptoms and percentage of children who ever had pneumonia by maternal report, or confirmed by the field worker.
Among HIV-uninfected children born to HIV-infected mothers, median percentage of days with diarrhea was 2.3% for 49 children allocated to vitamin A; 2.5% in 47 children allocated to receive vitamin A and zinc; and 2.2% for 46 children allocated to multiple micronutrients (P = 0.852). Among HIV-uninfected children born to HIV-uninfected mothers, median percentage of days of diarrhea was 2.4% in 56 children in the vitamin A group; 1.8% in 57 children in the vitamin A and zinc group; and 2.7% in 52 children in the multiple micronutrient group (P = 0.857). Only 32 HIV-infected children were enrolled, and there were no differences between treatment arms in the prevalence of diarrhea. The prevalence of upper respiratory symptoms or incidence of pneumonia did not differ by treatment arms in any of the cohorts.
When compared with vitamin A alone, supplementation with zinc, or with zinc and multiple micronutrients, did not reduce diarrhea and respiratory morbidity in rural South African children.
ClinicalTrials.gov NCT00156832.

Download full-text

Full-text

Available from: Kany-Kany Angelique Luabeya, Sep 01, 2015
0 Followers
 · 
151 Views
 · 
43 Downloads
  • Source
    • "Data on the effect of zinc supplementation on total mortality were available from 8 trials [9,10,22,23,25], which included 87,854 children and reported 1,558 events of mortality. We noted that zinc supplementation showed a 24% reduction in total mortality; however, there was no supporting evidence to show that zinc supplementation protected against total mortality risk (RR, 0.76; 95%CI: 0.56–1.04, "
    [Show abstract] [Hide abstract]
    ABSTRACT: Previous trials have shown that zinc supplementation can decrease the risk of diarrhea, pneumonia, and malaria in children; however, the effects of zinc supplementation on mortality remain unclear. This study aimed at evaluating the benefits and risks of zinc supplementation on both total mortality and cause-specific mortality. We searched PubMed, EmBase, and the Cochrane Central Register of Controlled Trials to identify randomized controlled trials in preschool children reporting total mortality or cause-specific mortality. Relative risk (RR) was used as a measure of the effect of zinc supplementation on the risk of mortality using a random effect model. Of the 1,520 identified articles, we included 8 trials reporting data on 87,854 children. Overall, zinc supplementation had no effect on total mortality (RR, 0.76; 95% CI: 0.56-1.04; P = 0.084), diarrhea-related mortality (RR, 0.80; 95% CI: 0.53-1.20; P = 0.276), pneumonia-related mortality (RR, 0.52; 95% CI: 0.11-2.39; P = 0.399), malaria-related mortality (RR, 0.90; 95% CI: 0.77-1.06; P = 0.196), or other causes of mortality (RR, 0.98; 95% CI: 0.67-1.44; P = 0.917). Subgroup analysis indicated that zinc supplementation was associated with a reduction in total mortality risk if the participants were boys, aged greater than 12 months, and the duration of the follow-up period was less than 12 months. Zinc supplementation does not have an effect on total mortality, diarrhea-related mortality, pneumonia-related mortality, malaria-related mortality, or other causes of mortality. Subgroup analysis suggested that zinc supplementation can effectively reduce the risk of total mortality if the participants were boys, aged greater than 12 months, and the duration of the follow-up period was less than 12 months.
    PLoS ONE 11/2013; 8(11):e79998. DOI:10.1371/journal.pone.0079998 · 3.23 Impact Factor
  • Source
    • "We also constructed 95% confidence intervals for the τ 2 statistic using non-parametric bootstrapping procedure [49] based on 5000 replicates. The two heterogeneity quantifying statistics have Bates et al 1993 Ninh et al 1996 Sazawal et al 1996 Rosado et al 1997 Ruel et al 1997 Sazawal et al 1997 Gardner et al 1998 Lira et al 1998 Umeta et al 2000 Shankar et al 2000 Muller et al 2001 Sazawal et al 2001 Rahman et al 2001 Osendarp et al 2002 Bhandari et al 2002 Baqui et al 2002 Baqui et al 2003 Gupta et al 2003 Sur et al 2003 Lind et al 2004 Penny et al 2004 Alarcon et al 2004 Brooks et al 2005 Heinig et al 2006 Sazawal et al 2006 Long et al 2006 Richard et al 2006 Tielsch et al 2007 Gupta et al 2007 Sazawal et al 2007 Bhandari et al 2007 Luabeya et al 2007 Brown et al 2007 Fischer Walker et al 2007 Taneja et al 2009 "
    [Show abstract] [Hide abstract]
    ABSTRACT: Prevention of diarrhea has presented indomitable challenges. A preventive strategy that has received significant interest is zinc supplementation. Existing literature including quantitative meta-analyses and systematic reviews tend to show that zinc supplementation is beneficial however evidence to the contrary is augmenting. We therefore conducted an updated and comprehensive meta-analytical synthesis of the existing literature on the effect of zinc supplementation in prevention of diarrhea. EMBASE®, MEDLINE ® and CINAHL® databases were searched for published reviews and meta-analyses on the use of zinc supplementation for the prevention childhood diarrhea. Additional RCTs published following the meta-analyses were also sought. Effect of zinc supplementation on the following five outcomes was studied: incidence of diarrhea, prevalence of diarrhea, incidence of persistent diarrhea, incidence of dysentery and incidence of mortality. The published RCTs were combined using random-effects meta-analyses, subgroup meta-analyses, meta-regression, cumulative meta-analyses and restricted meta-analyses to quantify and characterize the role of zinc supplementation with the afore stated outcomes. We found that zinc supplementation has a modest beneficial association (9% reduction) with incidence of diarrhea, a stronger beneficial association (19% reduction) with prevalence of diarrhea and occurrence of multiple diarrheal episodes (28% reduction) but there was significant unexplained heterogeneity across the studies for these associations. Age, continent of study origin, zinc salt and risk of bias contributed significantly to between studies heterogeneity. Zinc supplementation did not show statistically significant benefit in reducing the incidence of persistent diarrhea, dysentery or mortality. In most instances, the 95% prediction intervals for summary relative risk estimates straddled unity. Demonstrable benefit of preventive zinc supplementation was observed against two of the five diarrhea-related outcomes but the prediction intervals straddled unity. Thus the evidence for a preventive benefit of zinc against diarrhea is inconclusive. Continued efforts are needed to better understand the sources of heterogeneity. The outcomes of zinc supplementation may be improved by identifying subgroups that need zinc supplementation.
    BMC Infectious Diseases 05/2011; 11(1):122. DOI:10.1186/1471-2334-11-122 · 2.61 Impact Factor
  • Source
    • "Mortality data was reported in ten papers comprising eight trials [17,19,21,26-28,30,31,34,35]. Of these, one was cluster RCT [30,34] and seven were individual RCTs [17,19,21,26,28,31,35]. One trial exclusively included infants < 12 months of age [21]; the other seven trials on mortality included children between 1 to 60 months of age [17,19,26,28,30,31,35]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Zinc deficiency is commonly prevalent in children in developing countries and plays a role in decreased immunity and increased risk of infection. Preventive zinc supplementation in healthy children can reduce mortality due to common causes like diarrhea, pneumonia and malaria. The main objective was to determine all-cause mortality and cause-specific mortality and morbidity in children under five in developing countries for preventive zinc supplementation. DATA SOURCES/ REVIEW METHODS: A literature search was carried out on PubMed, the Cochrane Library and the WHO regional databases to identify RCTs on zinc supplementation for greater than 3 months in children less than 5 years of age in developing countries and its effect on mortality was analyzed. The effect of preventive zinc supplementation on mortality was given in eight trials, while cause specific mortality data was given in five of these eight trials. Zinc supplementation alone was associated with a statistically insignificant 9% (RR = 0.91; 95% CI: 0.82, 1.01) reduction in all cause mortality in the intervention group as compared to controls using a random effect model. The impact on diarrhea-specific mortality of zinc alone was a non-significant 18% reduction (RR = 0.82; 95% CI: 0.64, 1.05) and 15% for pneumonia-specific mortality (RR = 0.85; 95% CI: 0.65, 1.11). The incidence of diarrhea showed a 13% reduction with preventive zinc supplementation (RR = 0.87; 95% CI: 0.81, 0.94) and a 19% reduction in pneumonia morbidity (RR = 0.81; 95% CI: 0.73, 0.90). Keeping in mind the direction of effect of zinc supplementation in reducing diarrhea and pneumonia related morbidity and mortality; we considered all the outcomes for selection of effectiveness estimate for inclusion in the LiST model. After application of the CHERG rules with consideration to quality of evidence and rule # 6, we used the most conservative estimates as a surrogate for mortality. We, therefore, conclude that zinc supplementation in children is associated with a reduction in diarrhea mortality of 13% and pneumonia mortality of 15% for inclusion in the LiST tool. Preventive zinc supplementation had no effect on malaria specific mortality (RR = 0.90; 95% CI: 0.77, 1.06) or incidence of malaria (RR = 0.92; 95 % CI 0.82-1.04). Zinc supplementation results in reductions in diarrhea and pneumonia mortality.
    BMC Public Health 04/2011; 11 Suppl 3(Suppl 3):S23. DOI:10.1186/1471-2458-11-S3-S23 · 2.32 Impact Factor
Show more